成年人溶酶体储存障碍的肺部表现
Siddhartha Narayanan1, Kristen Catherman1, Nathan Pajor2
1Division of Pulmonary Critical Care and Sleep Medicine, Department of Internal Medicine, University of Cincinnati College of Medicine, Cincinnati, OH 45267, USA.
Clinics in chest medicine
|October 19, 2025
概括
罕见的溶酶体储存障碍,如酸髓酶缺乏症 (ASMD),高歇氏病 (GD) 和法布里病 (FD) 可以导致早期发病的肺部疾病. 识别关键症状并启动酶替代疗法可以保存器官并改善患者的结果.
科学领域:
- 肺部医学 肺部医学
- 遗传学 是一个遗传学.
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 溶酶体储存障碍 (LSD) 是一种罕见的遗传代谢疾病.
- 酸髓酶缺乏症 (ASMD),高氏病 (GD) 和法布里病 (FD) 是可能表现为肺部并发症的LSD.
- 在患有间歇性肺病 (ILD) 或慢性阻塞性肺病 (COPD) 的年轻患者中,这些情况经常被忽视.
研究的目的:
- 突出考虑LSD在年轻患有不明原因ILD或COPD的患者中的重要性.
- 概述关键的临床和放射学线索,表明特定的LSDs.
- 强调早期诊断和治疗与LSD相关的肺病的潜在好处.
主要方法:
- 对ASMD,GD和FD患者的临床表现和诊断结果的审查.
- 分析特征性症状,如大,肝大和血小板狭窄症.
- 特定的放射性发现 (例如,CT上的疯狂铺路模式) 和生物化学标记 (例如,低HDL) 与LSD诊断的相关性.
主要成果:
- 脊髓巨变,肝病巨变和血小板缺血在GD和ASMD中很常见.
- 胸部CT上的疯狂铺路模式和低HDL胆固醇表明ASMD.
- 阻塞性肺病是法布里病的一个关键特征.
结论:
- 对于早期发病的肺病患者来说,早期识别LSD至关重要.
- 特定的临床和放射学迹象可以帮助诊断ASMD,GD和FD.
- 及时的酶替代疗法可以在患有LSD的患者中导致器官保存和更好的结果.
相关概念视频
01:22Lysosomal Hydrolases
4.4K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
4.4K
01:17Other Pulmonary Disorders
1.5K
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
1.5K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.5K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.5K
01:20COPD: Pathogenesis and Clinical Features
1.8K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.8K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.2K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.2K
01:22Chronic Obstructive Pulmonary Disease
2.2K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.2K